FINWIRES · TerminalLIVE
FINWIRES

ASML EUV Demand Outpacing Supply, Pointing to Strong Growth in 2027, RBC Says

-- ASML's (ASML) Q2 outlook fell short of consensus, but demand for extreme ultraviolet systems is exceeding supply and output forecasts, pointing to strong growth in 2027, RBC Capital Markets said Wednesday in a note.

Q1 results exceeded Wall Street and RBC estimates, while management expects Q2 revenue of 8.7 billion euros ($10.24 billion) at the midpoint, above RBC's estimate of 8.5 billion euros but below consensus of 9.1 billion euros, according to the note.

Management raised 2026 revenue guidance to 36 billion to 40 billion euros from 34 billion to 39 billion euros on strong AI demand. RBC lifted its 2026 and 2027 EPS estimates to 31.78 euros and 40.24 euros from 28.32 euros and 33.93 euros, respectively.

Memory supply is expected to remain constrained beyond 2026 while EUV intensity is rising with the adoption of 1c/1-gamma nodes. The brokerage said it expects advanced Logic to rebound strongly in H2 and sees stronger competition at the leading edge as a structural positive.

RBC maintained an outperform rating on ASML and raised the price target to $1,700 from $1,625.

Price: $1424.56, Change: $-57.21, Percent Change: -3.86%

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605